# CLORAZEPATE DIPOTASSIUM

NDC: 13107-320
Generic name: CLORAZEPATE DIPOTASSIUM
Labeler / Manufacturer: Aurolife Pharma LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 19870717
Marketing ended: 20270228
FDA application: ANDA071858

## Active ingredients

- CLORAZEPATE DIPOTASSIUM: 7.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"13107-320"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=13107-320
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=919cbd07-f587-4005-acff-26213dd1d1fb